We have previously reported on AbbVie’s first and second wave suits against Alvotech hf. (Alvotech) in the Northern District of Illinois regarding an adalimumab biosimilar. In the second wave suit, on December 21, 2021,...more
We have previously reported on AbbVie’s first and second wave suits against Alvotech hf (Alvotech) in the Northern District of Illinois regarding an adalimumab biosimilar. In the first wave suit, on October 5, 2021 AbbVie...more
12/14/2021
/ AbbVie ,
Affirmative Defenses ,
Biosimilars ,
Counterclaims ,
Failure To State A Claim ,
Inequitable Conduct ,
Motion to Dismiss ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Personal Jurisdiction ,
Pharmaceutical Patents ,
Subject Matter Jurisdiction ,
Unclean Hands